The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2737–2760 of 3,526
Equillium, Inc. has announced the acceptance of preclinical data for their investigational compound, EQ504, at the upcoming IMMUNOLOGY2026™ conference. This...
RenovoRx, Inc. has secured a Notice of Allowance for its first Japanese patent application, enhancing the intellectual property protection for its RenovoC...
Ascendis Pharma has reported significant findings from the ongoing Phase 2 COACH Trial, demonstrating that the combination therapy of TransCon CNP and Tra...
Pacira BioSciences, Inc. has announced its participation in the 25th Annual Needham Virtual Healthcare Conference on April 15, 2026, where it will engage in an...
Amarin Corporation has underscored the critical role of icosapent ethyl (IPE) in managing residual cardiovascular (CV) risk at the 2026 American College...
Biora Therapeutics has reported over 25% oral bioavailability for its innovative BioJet™ platform, a swallowable autoinjector designed for the oral delivery...
CorTec GmbH has received Breakthrough Device Designation from the FDA for its Brain Interchange™ system, a fully implantable brain-computer interface (B...
HealthBook+ has launched HealthBook+ 2.0, an advanced clinical intelligence solution, at the Hint Summit 2026. This updated platform features a significantl...
Kiniksa Pharmaceuticals has launched the Heart’s Home™ campaign to enhance awareness and empower patients regarding ARCALYST, the first FDA-approved the...
ModeX Therapeutics has initiated a Phase 1 clinical trial for MDX2301, a tetravalent bispecific antibody aimed at preventing COVID-19 by neutralizing al...
The global infusion pumps and devices market is projected to expand from $9 billion in 2024 to $14.2 billion by 2030, representing a compound annual g...
Leto Tech PBC has launched an innovative software platform designed to enhance the efficiency of connecting clients with community resources, functioning as a c...
iBio, Inc. has announced the initiation of a first-in-human clinical trial for IBIO-600, a long-acting anti-myostatin monoclonal antibody aimed at preservin...
Immusoft has announced a significant milestone in the field of engineered B cell therapies, presenting the world’s first clinical case review of their investiga...
MEDvidi has launched its AI Prescribing Assistant, designed to streamline medication renewals for patients with ADHD, anxiety, and depression. This innovati...
Radiopharm Theranostics has received a positive recommendation from its Data Safety and Monitoring Committee (DSMC) to escalate the dose of its clinical-sta...
Researchers have identified the aryl hydrocarbon receptor (AhR) as a critical regulator of axon regeneration in the nervous system, revealing its dual role...
Rubedo Life Sciences has announced promising preliminary results from a Phase 1 clinical trial of its senolytic drug RLS-1496, which targets the GPX4 me...
AtaiBeckley Inc. has reported promising Phase 2a results for BPL-003 (mebufotenin benzoate), an intranasal treatment for treatment-resistant depre...
Givaudan Active Beauty has announced a collaboration with Haut.AI to showcase AI-driven ingredient demonstrations at in-cosmetics Global 2026 in Paris, set...
Cognition Therapeutics is poised to share pivotal updates on its Alzheimer’s disease and dementia with Lewy bodies programs, as President and CEO Lisa Ricciardi...
Alzheon has initiated a Phase 1 trial for ALZ-507, an oral small molecule designed to inhibit the formation of neurotoxic soluble amyloid oligomers while incorp...
NeuroSense has secured Brazilian Patent No. BR 112024007727-6 for its PrimeC composition, which combines ciprofloxacin and celecoxib in a unique syn...
BudPop's recent internal survey reveals a significant shift in consumer preferences within the hemp edibles market, with 68% of respondents moving away from...